Gals Bio
Gals Bio is pioneering a new category in women’s health and wellness called Fem-Wearables.
StartupGals Bio is a Mevaseret Zion-based startup in the Health Tech & Life Sciences sector, established in 2015. Gals Bio is pioneering a new category in women’s health and wellness called Fem-Wearables. . The company has raised a total of $1.96M across 2 funding rounds, currently at the Pre-Seed stage. Gals Bio was founded by Hilla Shaviv. Key investors include PipelBiz, AH trust. The company has 1-10 employees. Core technologies: Semiconductors & Electronics, Wearables, Materials & Substances, Polymers, Sensing.
With $1.96M in total funding, Gals Bio is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C/B2C/B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePre-Seed
- ProductClinical Trial
- ModelB2B2C, B2C, B2B
- Employees1-10
- HQMevaseret Zion
- DistrictJerusalem District
- Last Round$463K
- PipelBiz
- AH trust
Hilla ShavivFounder & CEO
1 article covered by sources including www.haaretz.com.
What does Gals Bio do?
Gals Bio is pioneering a new category in women’s health and wellness called Fem-Wearables. By leveraging the unique vaginal environment and integrating AI-powered analysis, we provide personalized, early, and accessible home health solutions that are accurate, affordable, and designed for early-stage detection. These solutions include rapid screening, monitoring, and therapeutic care for women’s health needs. Tulipon our first device enables clean collection of vaginal secretions for cancer screening. Women of any age with abnormal bleeding, BRCA mutations, or high cancer risk can use Tulipon for up to 12 hours. Its liquid-lock mechanism preserves the sample, which is then sent to a lab for AI-powered liquid biopsy analysis. Tulipon minimizes human interference, preventing errors and contamination. Its absorbent-free design ensures access to all fluids and tissue secretions, empowering early detection, convenience, and proactive reproductive health diagnostics.
How much funding has Gals Bio raised?
Gals Bio has raised $1.96M in total funding across 2 rounds. The company is currently at the Pre-Seed stage. Key investors include PipelBiz, AH trust.
Who founded Gals Bio?
Gals Bio was founded in 2015 by Hilla Shaviv (Founder & CEO).
What sector is Gals Bio in?
Gals Bio operates in Health Tech & Life Sciences, Medical Devices, Diagnostics Devices, Digital Healthcare, Digital Medical Diagnostics, with core technologies in Semiconductors & Electronics, Wearables, Materials & Substances, Polymers, Sensing. Target customers: Consumers, Demographics & Family, Women, Healthcare & Life Sciences, Healthcare, Providers, Patients.
Where is Gals Bio located?
Gals Bio is based in Mevaseret Zion, Israel, Jerusalem District.